Author

Xu Qingyong

University of Pittsburgh Medical Center - Cited by 1,114 - Pathology

Biography

Dr. Xu has more than 10-year experience in clinical histocompatibility and immunogenetics, and has been directors of ASHI-certified HLA labs in Canada. He was known for his expertise in new lab setup, test utilization and quality improvement. Currently Dr. Xu is the Associate Director of Histocompatibility (Tissue Typing) Lab at UPMC.
Title
Cited by
Year
Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff
J McCaughan, Q Xu, K TinckamHepatobiliary surgery and nutrition 8 (1), 37, 2019201
46
2019
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and …
L Wang, Y Xie, KA Ahmed, S Ahmed, A Sami, R Chibbar, Q Xu, SE Kane, ...Breast cancer research and treatment 140, 273-284, 2013201
44
2013
Differential requirements of CD4+ T‐cell signals for effector cytotoxic T‐lymphocyte (CTL) priming and functional memory CTL development at higher CD8+ T‐cell …
CS Umeshappa, RH Nanjundappa, Y Xie, A Freywald, Q Xu, J XiangImmunology 138 (4), 298-306, 131
20
2013
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction
CJ Iasella, CR Ensor, M Marrari, M Mangiola, Q Xu, E Nolley, CA Moore, ...The Journal of Heart and Lung Transplantation 39 (12), 1417-1425, 2020202
16
2020
Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation
Q Xu, VC McAlister, S Leckie, AA House, A Skaro, P MarottaAmerican Journal of Transplantation 20 (1), 282-288, 2020202
15
2020
Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates
R Sriwattanakomen, Q Xu, M Demehin, MA Shullo, M Mangiola, ...The Journal of Heart and Lung Transplantation 40 (7), 595-603, 2021202
11
2021
Positive flow cytometry crossmatch with discrepant antibody testing results following COVID-19 vaccination
Q Xu, P Sood, D Helmick, JS Lomago, AD Tevar, A ZeeviAmerican Journal of Transplantation 21 (), 3785-3789, 2021202
11
2021
Early findings after integration of donor‐derived cell‐free DNA into clinical care following pediatric heart transplantation
B Feingold, K Rose‐Felker, SC West, MD Zinn, P Berman, A Moninger, ...Pediatric Transplantation 26 (1), e14124, 2022202
11
2022
Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy
R Mainra, Q Xu, R Chibbar, A Hassan, A ShokerTransplant Immunology 28 (4), 145-147, 2013201
9
2013
The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation
Q Xu, B Shrum, S Leckie, A Skaro, VC McAlisterHepatobiliary Surgery and Nutrition 8 (3), 246, 2019201
7
2019
Precision transplant pathology
MA Wood-Trageser, Q Xu, A Zeevi, P Randhawa, D Lesniak, AJ DemetrisCurrent opinion in organ transplantation 25 (4), 412, 2020202
6
2020
Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation
Q Xu, VC McAlister, AA House, M Molinari, S Leckie, A ZeeviClinical transplantation 3 (7), e14318, 2021202
5
2021
Patients with immunological diseases or on peritoneal dialysis are prone to false positive flow cytometry crossmatch
Q Xu, AA House, S Leckie, L Gunaratnam, PP Luke, AM JevnikarHuman Immunology 80 (7), 487-492, 2019201
5
2019
Approaching the sensitized lung patient: risk assessment for donor acceptance
M Mangiola, M Marrari, Q Xu, PG Sanchez, A ZeeviJournal of Thoracic Disease 13 (11), 6725, 2021202
4
2021
Validation of the liver transplant risk score in Europe
E Ashwat, C Kaltenmeier, H Liu, D Reddy, A Thompson, S Dharmayan, ...British Journal of Surgery 110 (), 02-05, 20220
3
2023
Differential Association Between Responder’s HLA-DR Phenotypes and HLD-DR Antibody Production in Patients Awaiting for Renal Transplantation; Analysis of UNOS Database
A Shoker, Q Xu, HJ LimJ Clin Exp Transplant 1, 103, 01601
2
2016
Choosing the right patient for lung transplantation: assessment of histocompatibility and sensitization status
Q Xu, M Mangiola, A ZeeviContemporary Lung Transplantation, -2, 2020202
1
2020
The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation.
Q Xu, A Skaro, V McAlisterAMERICAN JOURNAL OF TRANSPLANTATION 8, 342-342, 20820
1
2018
OR 47 Allele-specific antibody to hla-dq alpha chain in a case of chronic antibody-mediated rejection
Q Xu, E Johnson, T Pearce, R LiwskiHuman Immunology 77, 27, 20620
1
2016
Significant Reduction of Donor Specific Antibodies in Heart Transplant Recipients Treated with Proteasome Inhibitors for Antibody Mediated Rejection
ET Horn, Q Xu, Z Tushak, M Binko, JN Dibridge, JH Huston, GW Hickey, ...The Journal of Heart and Lung Transplantation 4 (4), S40-S4, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=0O4glfUAAAAJ&hl=en

Cited by
Citations 1114
h-index 14
i10-index 18
Recommended Journals
Open Access Journals